Ana María
Estévez Braun
Catedrática de Universidad
![Foto de Ana María](/img/uploaded/A54B0273BBEC78B2FEC875AE6DAD7558.jpg)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (6)
2022
-
Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking
Pharmaceuticals, Vol. 15, Núm. 7
2020
-
Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation
Journal of Natural Products, Vol. 83, Núm. 7, pp. 2155-2164
2019
-
Metal complexes of natural product like-compounds with antitumor activity
Anti-Cancer Agents in Medicinal Chemistry, Vol. 19, Núm. 1, pp. 48-65
-
α-hispanolol induces apoptosis and suppresses migration and invasion of glioblastoma cells likely via downregulation of MMP-2/9 expression and p38MAPK attenuation
Frontiers in Pharmacology, Vol. 10, Núm. JULY
2018
-
Semisynthesis and inhibitory effects of solidagenone derivatives on TLR-mediated inflammatory responses
Molecules, Vol. 23, Núm. 12
2015
-
Biological evaluation of angular disubstituted naphthoimidazoles as anti-inflammatory agents
Bioorganic and Medicinal Chemistry Letters, Vol. 25, Núm. 19, pp. 4210-4213